NEW YORK, July 26 (Reuters) - A U.S. appeals court has
affirmed a decision that ended J&J's second attempt to resolve
tens of thousands of cancer lawsuits through a shell company's
bankruptcy, while J&J pushes ahead with its third bankruptcy
gambit.
The 3rd U.S. Circuit Court of Appeals on Thursday ruled that
the company's second effort, like its first, had to fail because
the shell company that it placed into bankruptcy was not in
"financial distress."
The decision was not a surprise to J&J, which is pressing
ahead with a revised effort to settle lawsuits alleging that its
baby powder and other talc products were contaminated with
asbestos and caused ovarian and other cancers.
J&J says that its talc products do not contain asbestos and
do not cause cancer, but it is pursuing a third bankruptcy in an
effort to end lawsuits from about 61,000 claimants and prevent
anyone from bringing similar lawsuits in the future.
J&J is collecting votes from people who allege they have
been injured by their talc, and it plans to place a shell
company into bankruptcy for a third time if it can get support
from 75% of those claimants. Votes on J&J's proposal are due
today, and J&J has said it may take a few weeks to count the
votes.
The 3rd Circuit decision found that the earlier bankruptcy
of J&J subsidiary LTL Management was properly dismissed by a
U.S. bankruptcy judge. LTL had presented only "speculative"
evidence that the talc lawsuits created sufficient "financial
distress" to warrant the protections of bankruptcy.
A three-judge panel of the appeals court rejected LTL's
argument that the "financial distress" standard was so
restrictive that it would shut off bankruptcy as an option for
companies facing large numbers of lawsuits.
"No doubt that solvent companies, confronted by mass-tort
litigation, can encounter significant financial distress that
warrants bankruptcy," Circuit Judge Thomas Ambro wrote for the
panel. "When future insolvency is a realistic possibility based
on meaningful evidence - not just the result of a highly
speculative 'worst-case' scenario - a mass-tort defendant has a
viable case for bankruptcy."
J&J intends to appeal to the U.S. Supreme Court, the
company's vice president of litigation Erik Haas said Friday.
But, the 3rd Circuit's ruling was expected and it will not
impact J&J's ongoing effort to gather support for its revised
settlement offer, Haas said.
J&J is confident that it will get votes from over 75% of
talc claimants, Haas said.
Andy Birchfield, an attorney representing people who have
filed ovarian cancer lawsuits against J&J, said the decision
should be a "warning to J&J" that its focus on a bankruptcy
settlement "is unlawful and also defies common sense."
J&J's bankruptcy strategy faces legal hurdles even if it
gets the 75% threshold it is seeking in its current voting
period.
The U.S. Supreme Court's recent ruling in Purdue Pharma's
bankruptcy narrowed courts' ability to stop lawsuits against
people and companies, like J&J, who are not bankrupt, without
the consent of the people who have sued. And attorneys opposed
to J&J's settlement offer will argue that the new deal still
fails under the "financial distress" standard articulated by the
3rd U.S. Circuit.
J&J says the Purdue ruling does not impact its settlement
proposal, because it qualifies for specific non-debtor
protections that U.S. bankruptcy law allows for asbestos
defendants.
New legislation proposed this week could also present an
obstacle by placing limits on the so-called "Texas two-step"
strategy that J&J used to place its talc liabilities into a
shell company. A bipartisan trio of Senators said that
financially healthy companies like J&J should not be allowed to
use bankruptcy courts to evade responsibility for injuries they
caused.
The Texas two-step tactic involves first using Texas
corporate law to split a business into two separate companies,
one that inherits the assets and a shell company which is
saddled with liabilities, including lawsuits. The shell company
then files for bankruptcy protection, and it uses its bankruptcy
to block lawsuits from proceeding against its well-funded
affiliates.
The case is In Re: LTL Management, U.S. Court of Appeals for
the Third Circuit, Nos. 23-2971 and 23-2972
For LTL: Gregory Gordon, Noel Francisco, and Kevin Marshall
of Jones Day
For the official committee of talc claimants: Jeffrey Lamken
of MoloLamken, Jonathan Massey of Massey & Gail
Read more:
The battle over J&J's bankruptcy plan to end talc lawsuit
J&J advances $6.48 billion settlement of talc cancer
lawsuits
US Senate bill aims to curb Texas two-step bankruptcies